Skip to main content

and
  1. Article

    Open Access

    Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC)

    Lung cancer is the leading cause of cancer-related death worldwide. Genetic and epigenetic alterations have been identified frequently in lung cancer, such as promoter methylation, gene mutations and genomic a...

    Meiju Ji, Haixia Guan, Cuixia Gao, Bingyin Shi, Peng Hou in BMC Cancer (2011)

  2. Article

    Open Access

    Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway

    MT1G inactivation mediated by promoter methylation has been reported in thyroid cancer. However, the role of MT1G in thyroid carcinogenesis remains unclear. The aim of this study is to examine the biological fun...

    Jiao Fu, Hongjun Lv, Haixia Guan, **aoying Ma, Meiju Ji, Nongyue He in BMC Cancer (2013)

  3. No Access

    Article

    miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL

    Mounting evidence has shown that microRNAs (miRNAs), a class of small non-coding RNAs, are frequently deregulated in human malignancies and have pivotal roles in diverse biological processes including cancer c...

    Lin Chen, Haitao Guan, Chunyan Gu, Yali Cao, Jianguo Shao, Feng Wang in Tumor Biology (2016)

  4. No Access

    Article

    SH3GL1 inhibition reverses multidrug resistance in colorectal cancer cells by downregulation of MDR1/P-glycoprotein via EGFR/ERK/AP-1 pathway

    Multidrug resistance is one of the major reasons colorectal cancer (CRC) chemotherapy-based treatments fail, and novel biologically based therapies are urgently needed. Src homology 3 (SH3)-domain GRB2-like pr...

    Haitao Guan, ** Zhao, Zhijun Dai, **aoxu Liu, ****g Wang in Tumor Biology (2016)

  5. Article

    Open Access

    CYP2S1 is a synthetic lethal target in BRAFV600E-driven thyroid cancers

    BRAFV600E is the most common genetic alteration and has become a major therapeutic target in thyroid cancers; however, intrinsic feedback mechanism limited clinical use of BRAFV600E specific inhibitors. Synthetic...

    Yiqi Li, ** Su, Chao Feng, Siyu Liu in Signal Transduction and Targeted Therapy (2020)

  6. Article

    Open Access

    LncRNA HOXA-AS2 promotes glioblastoma carcinogenesis by targeting miR-885-5p/RBBP4 axis

    LncRNA HOXA-AS2 has been found in the literature to deteriorate glioblastoma. However, its regulatory mechanism is yet to be fully investigated. Our study focused chiefly on the interaction and role of the HOX...

    Jixin Shou, Haidong Gao, Sen Cheng, Bingbing Wang, Haibo Guan in Cancer Cell International (2021)

  7. Article

    Open Access

    Long-term outcome of percutaneous radiofrequency ablation for periportal hepatocellular carcinoma: tumor recurrence or progression, survival and clinical significance

    Recent studies have suggested that periportal location of percutaneous radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) is considered as one of the independent risk factors for local tumor prog...

    Shou** Cao, Tianshi Lyu, Zeyang Fan, Haitao Guan, Li Song in Cancer Imaging (2022)

  8. Article

    Open Access

    Evaluating the progression to abnormal thyrotropin in euthyroid preconception women: a population-based study

    Abnormal preconception thyrotropin levels were associated with fecundability and adverse fetomaternal outcomes, however, little is known regarding the natural change of serum thyrotropin in euthyroid preconce...

    Rili Gao, **nyi Lyu, Ying Yang, **rong Fu, Chuanyu Zhao, Haixia Guan in Thyroid Research (2024)